{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:06:01Z","timestamp":1791025561679,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,1]]},"DOI":"10.1007\/bf01789132","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T12:49:49Z","timestamp":1119271789000},"page":"57-60","source":"Crossref","is-referenced-by-count":47,"title":["Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: A pilot study"],"prefix":"10.1007","volume":"36","author":[{"given":"Bruce J.","family":"Dezube","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L.","family":"Fridovich-Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Allen-Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur B.","family":"Pardee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01789132_CR1","first-page":"5602","volume":"51","author":"D Aderka","year":"1991","unstructured":"Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G (1991) Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 51: 5602\u20135607","journal-title":"Cancer Res"},{"key":"BF01789132_CR2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(87)91850-2","volume":"II","author":"F Balkwill","year":"1987","unstructured":"Balkwill F, Burke F, Talbot D, Tavernier J, Osborne R, Naylor S, Durbin H, Fiers W (1987) Evidence for tumor necrosis factor\/cachectin production in cancer. Lancet II: 1229\u20131232","journal-title":"Lancet"},{"key":"BF01789132_CR3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V74.1.165.165","volume":"74","author":"KA Bauer","year":"1989","unstructured":"Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74: 165\u2013172","journal-title":"Blood"},{"key":"BF01789132_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJM198702123160705","volume":"316","author":"B Beutler","year":"1987","unstructured":"Beutler B, Cerami A (1987) Cachectin: more than a tumor necrosis factor. N Engl J Med 316: 379\u2013385","journal-title":"N Engl J Med"},{"key":"BF01789132_CR5","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.4049\/jimmunol.135.6.3972","volume":"135","author":"BA Beutler","year":"1985","unstructured":"Beutler BA, Milsark IW, Cerami A (1985) Cachectin\/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 135: 3972\u20133977","journal-title":"J Immunol"},{"key":"BF01789132_CR6","first-page":"165","volume-title":"Proceedings of a Symposium: Pentoxifylline and leukocyte function","author":"M Boogaerts","year":"1988","unstructured":"Boogaerts M (1988) In vivo and in vitro modulation of normal and diseased human neutrophil function by pentoxifylline. In: Mandell GL, Novick WJ (eds) Proceedings of a Symposium: Pentoxifylline and leukocyte function, Somerville, N. J. Hoechst-Roussel Pharmaceuticals, pp 165\u2013174"},{"key":"BF01789132_CR7","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/bi00591a005","volume":"18","author":"JM Chirgwin","year":"1979","unstructured":"Chirgwin JM, Pryzybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294\u20135299","journal-title":"Biochemistry"},{"key":"BF01789132_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-8674(80)90238-X","volume":"20","author":"DW Cleveland","year":"1980","unstructured":"Cleveland DW, Lopata MA, MacDonald RJ, Cowan NJ, Rutter WJ, Kirschner MW (1980) Number and evolutionary conservation of \u03b1-and \u03b2-tubulin and cytoplasmic \u03b2- and \u03b3-actin genes using specific cloned DNA probes. Cell 20: 95\u2013105","journal-title":"Cell"},{"key":"BF01789132_CR9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0140-6736(90)90450-J","volume":"335","author":"BJ Dezube","year":"1990","unstructured":"Dezube BJ, Fridovich-Keil JL, Bouvard I, Lange RF, Pardee AB (1990) Pentoxifylline and wellbeing in patients with cancer. Lancet 335: 662","journal-title":"Lancet"},{"key":"BF01789132_CR10","unstructured":"Dezube BJ, Pardee AB, Beckett LA, Ahlers CM, Ecto L, Allen-Ryan J, Anisowicz A, Sager R, Crumpacker CS (1992) Cytokine dysregulation in AIDS: the in vivo overexpression of mRNA of tumor necrosis factor-\u03b1 and its correlation with that of the inflammatory cytokine GRO. J Acquir Immune Defic Syndr (in press)"},{"key":"BF01789132_CR11","unstructured":"Dezube BJ, Pardee AB, Chapman B, Beckett L, Korvick J, Ahlers CM, Ecto L, Chatis P, Crumpacker CS and ACTB 160 team (1992) Pentoxifylline (Trental) decrases tumor necrosis factor (TNF) and HIV replication in patients with AIDS (abstract MoB 0019). Proceedings VIII International Conference on AIDS, (Amsterdam, The Netherlands)"},{"key":"BF01789132_CR12","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.86.15.5974","volume":"86","author":"EJ Duh","year":"1989","unstructured":"Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB (1989) Tumor necrosis factor \u03b1 activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat. Proc Natl Acad Sci USA 86: 5974\u20135978","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01789132_CR13","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1182\/blood.V77.8.1653.1653","volume":"77","author":"F Fazely","year":"1991","unstructured":"Fazely F, Dezube BJ, Allen-Ryan J, Pardee AB, Ruprecht RM (1991) Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood 77: 1653\u20131656","journal-title":"Blood"},{"key":"BF01789132_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9343(88)90576-1","volume":"85","author":"J Lahdevirta","year":"1988","unstructured":"Lahdevirta J, Maury CPJ, Teppo A-M, Repo H (1988) Elevated levels of circulating cachectin\/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 85: 289\u2013291","journal-title":"Am J Med"},{"key":"BF01789132_CR15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1164\/ajrccm\/139.6.1361","volume":"139","author":"CM Lilly","year":"1989","unstructured":"Lilly CM, Sandhu JS, Ishizaka A, Harada H, Yonemaru M, Larrick JW, Shi T-X, O'Hanley PT, Raffin TA (1989) Pentoxifylline prevents tumor necrosis factor-induced lung injury. Am Rev Respir Dis 139: 1361\u20131368","journal-title":"Am Rev Respir Dis"},{"key":"BF01789132_CR16","first-page":"1","volume":"4","author":"SF Lowry","year":"1990","unstructured":"Lowry SF, Moldawer LL (1990) Tumor necrosis factor and other cytokines in the pathogenesis of cancer cachexia. Principles and Practice of Oncology Updates 4: 1\u201312","journal-title":"Principles and Practice of Oncology Updates"},{"key":"BF01789132_CR17","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0024-3205(90)90474-6","volume":"47","author":"P Noel","year":"1990","unstructured":"Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G, Summer W (1990) Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci 47: 1023\u20131029","journal-title":"Life Sci"},{"key":"BF01789132_CR18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","volume":"50","author":"A Oliff","year":"1987","unstructured":"Oliff A, Defeo-Jones D, Boyer M, Martinez D, Kiefer D, Vuocolo G, Wolfe A, Socher SH (1987) Tumors secreting human TNF\/cachectin induce cachexia in mice. Cell 50: 555\u2013563","journal-title":"Cell"},{"key":"BF01789132_CR19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1073\/pnas.87.2.782","volume":"87","author":"G Poli","year":"1990","unstructured":"Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, Fauci AS (1990) Tumor necrosis factor \u03b1 functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci USA 87: 782\u2013785","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01789132_CR20","volume-title":"Molecular cloning. A laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory, New York"},{"key":"BF01789132_CR21","first-page":"171","volume":"31","author":"UF Schade","year":"1990","unstructured":"Schade UF (1990) Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock 31: 171\u2013181","journal-title":"Circ Shock"},{"key":"BF01789132_CR22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.1988.6.2.344","volume":"6","author":"ML Sherman","year":"1988","unstructured":"Sherman ML, Spriggs DR, Arthur KA, Imamura K, Frei III E, Kufe DW (1988) Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism. J Clin Oncol 6: 344\u2013350","journal-title":"J Clin Oncol"},{"key":"BF01789132_CR23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0006-291X(88)81271-3","volume":"155","author":"RM Strieter","year":"1988","unstructured":"Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch III JP, Larrick J, Kunkel SL (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155: 1230\u20131236","journal-title":"Biochem Biophys Res Commun"},{"key":"BF01789132_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1126\/science.3856324","volume":"228","author":"AM Wang","year":"1985","unstructured":"Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R, Mark DF (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228: 149\u2013154","journal-title":"Science"},{"key":"BF01789132_CR25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2165\/00003495-198734010-00003","volume":"34","author":"A Ward","year":"1987","unstructured":"Ward A, Clissold SP (1987) Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34: 50\u201397","journal-title":"Drugs"},{"key":"BF01789132_CR26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0140-6736(89)92929-2","volume":"II","author":"P Zabel","year":"1989","unstructured":"Zabel P, Schonharting MM, Wolter DT, Schade UF (1989) Oxpentifylline in endotoxaemia. Lancet II: 1474\u20131477","journal-title":"Lancet"},{"key":"BF01789132_CR27","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/ajrccm\/142.5.1073","volume":"142","author":"H Zheng","year":"1990","unstructured":"Zheng H, Crowley JJ, Chan JC, Hoffman H, Hatherill JR, Ishizaka A, Raffin TA (1990) Attenuation of tumor necrosis factor-induced endothelial cytotoxicity and neutrophil chemiluminescence. Am Rev Respir Dis 142: 1073\u20131078","journal-title":"Am Rev Respir Dis"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01789132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01789132\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01789132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T12:57:45Z","timestamp":1683118665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01789132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["BF01789132"],"URL":"https:\/\/doi.org\/10.1007\/bf01789132","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}